Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07089888 · ClinicalTrials.gov registry record · Phase 3
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Phase 3 study of Tophaceous Gout, sponsored by Crystalys Therapeutics.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 20
- Study locations
NCT07089888 is a Phase 3 study of Tophaceous Gout that is actively recruiting participants, run by Crystalys Therapeutics. The registered enrollment target is 250 participants. The trial reports 20 study locations across 5 states.
The verdict
NCT07089888, a Phase 3 study of Tophaceous Gout, is actively recruiting participants, sponsored by Crystalys Therapeutics.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with tophaceous gout.
Conditions Studied
Interventions
- DRUG Allopurinol
- DRUG Dotinurad
Study Locations (20)
California
- Medvin Clinical Research - Covina - Covina
- West Coast Research - Dublin
- Infinity Clinical Research - Norco
- Amicis Research Center - Balboa - Northridge
- Dream Team Clinical Research - Pomona
- Acclaim Clinical Research, Inc. - San Diego
- East Bay Rheumatology Medical Group - San Leandro
- BTC Network - Encompass Clinical Research - Spring Valley
- Cohen Medical Centers - Thousand Oaks
- Medvin Clinical Research - Tujunga - Tujunga
Arizona
- Arizona Arthritis & Rheumatology Associates (AARA) - Gilbert - Gilbert
- Arizona Arthritis & Rheumatology Associates (AARA) - Glendale - Glendale
- Arizona Arthritis & Rheumatology Associates (AARA) - Mesa - Mesa
- Del Sol Research Management - Tucson East - Tucson
Florida
- Bradenton Research Center - Bradenton
- Herco Medical and Research Center, Inc - Coral Gables
- New Generation of Medical Research - Hialeah
Alabama
- Alabama Clinical Therapeutics - Birmingham
- G & L Research - Foley
Colorado
- Denver Arthritis Clinic - Lowry - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07089888
The ClinicalTrials.gov registry entry for NCT07089888 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Crystalys Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tophaceous Gout appearing as the primary indexed condition, and to 2 interventions - of which Allopurinol is the first listed.
NCT07089888 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT07089888 about?
NCT07089888 is a clinical study titled "A Study of Dotinurad Versus Allopurinol in Tophaceous Gout". The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with tophaceous gout.
What is the current status of trial NCT07089888?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2025-08-04. Estimated completion is 2027-12-31.
What conditions does trial NCT07089888 study?
This clinical trial studies the following conditions: Tophaceous Gout.
What interventions are being tested in trial NCT07089888?
The interventions under investigation include: Allopurinol (DRUG), Dotinurad (DRUG).
Who is sponsoring clinical trial NCT07089888?
This trial is sponsored by Crystalys Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07089888 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tophaceous Gout
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.